| Abstract |
Objective: To investigate the clinical efficacy of femoston combined with Kuntai Capsule in the treatment of menopausal depression and its impact on sleep quality.Methods: 58 cases of menopausal depression patients admitted to our hospital from May 2018 to May 2019,According to the computer digital table method randomly divided into two groups , each group of 29 cases,The control group was treated with femoston, and the experimental group was treated with femoston and Kuntai capsules. The efficacy and sleep quality improvement of the two groups were compared.Results: After treatment, the follicle stimulating hormone in the experimental group was (53.61±2.17) U/L, which was lower than that of the control group (62.51±2.25) U/L, and estradiol was (68.32±2.13) pmol/L, compared with the control group. (60.24±2.25) pmol/L high, with statistically significant (P<0.05).After treatment, the kupperman index, hamilton depression scale are lower than the control group,with statistically significant (P<0.05).After treatment, the sleep quality, sleep time and sleep disorder scores in the Pizids sleep quality index table were lower than those in the control group, with statistically significant (P<0.05).Conclusion: Menopausal depression can effectively improve sex hormone levels, menopause and depressive symptoms through the combination of femoston and Kuntai Capsules, thus improving their sleep quality.
|